Myositis ossificans

MONDO:0003964

A disorder characterized by non-neoplastic bone formation in soft tissues. It usually follows blunt trauma and bleeding in the deep soft tissues.

Also known as: FOP, myositis ossificans progressiva, progressive myositis ossificans, progressive ossifying myositis, fibrodysplasia ossificans progressiva

13 clinical trials for this condition and its sub-types, 11 tagged with Myositis ossificans itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Myositis disease (298)

Sub-types of Myositis ossificans

Traumatic myositis ossificans 0 trials

Including sub-types (13) Tagged with Myositis ossificans (11)

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 5 Terminated 1

Promising antibody trial aims to halt rare bone disease in kids

Disease control Not yet recruiting

This Phase 3 trial tests garetosmab, an antibody that blocks activin A, in 18 children and teens with fibrodysplasia ossificans progressiva (FOP), a rare disease where muscle and tissue turn into bone. The study will check safety, side effects, and whether the drug reduces new ab…

Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Aug 26, 2026 00:00 UTC

Myositis ossificans

Where it sits in the disease tree

Promising antibody trial aims to halt rare bone disease in kids